Kwon A et al. |
Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. |
2016 |
Medicine (Baltimore) |
pmid:27082605
|
Verde ME et al. |
Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. |
2015 |
Acta Odontol Latinoam |
pmid:27095621
|
|
|
|
|
pmid:27105133
|
Wang S et al. |
Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. |
2016 |
J Ethnopharmacol |
pmid:27109342
|
Li B et al. |
Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. |
2016 |
Int J Mol Sci |
pmid:27110777
|
|
|
|
|
pmid:27111559
|
Yuan SY et al. |
Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. |
2016 |
Chin J Nat Med |
pmid:27114313
|
|
|
|
|
pmid:27119523
|
|
|
|
|
pmid:27128817
|
|
|
|
|
pmid:27145458
|
|
|
|
|
pmid:27154288
|
|
|
|
|
pmid:27156396
|
|
|
|
|
pmid:27163932
|
Usategui-MartÃn R et al. |
VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone. |
2016 |
Genet Test Mol Biomarkers |
pmid:27172236
|
|
|
|
|
pmid:27188231
|
|
|
|
|
pmid:27196016
|
Wei CC et al. |
Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. |
2016 |
Mediators Inflamm. |
pmid:27199510
|
Bernardi S et al. |
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. |
2016 |
Biomed Res Int |
pmid:27200369
|
|
|
|
|
pmid:27209224
|
|
|
|
|
pmid:27225733
|
|
|
|
|
pmid:27234754
|
|
|
|
|
pmid:27235726
|
|
|
|
|
pmid:27255234
|
|
|
|
|
pmid:27256330
|
Majerczyk M et al. |
[Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. |
2015 |
Postepy Hig Med Dosw (Online) |
pmid:27259222
|
Gautam J et al. |
An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. |
2016 |
J. Pharm. Pharmacol. |
pmid:27265669
|
Ye C et al. |
[Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. |
2016 |
Hua Xi Kou Qiang Yi Xue Za Zhi |
pmid:27266195
|
|
|
|
|
pmid:27270654
|
|
|
|
|
pmid:27271452
|
He M et al. |
Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. |
2016 |
Mol Med Rep |
pmid:27277157
|
|
|
|
|
pmid:27278225
|
Yamada C et al. |
TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts. |
2016 |
Int. J. Oncol. |
pmid:27279422
|
|
|
|
|
pmid:27279652
|
|
|
|
|
pmid:27301430
|
|
|
|
|
pmid:27307249
|
Wang JH et al. |
Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. |
2016 |
Medicine (Baltimore) |
pmid:27310953
|
Kassem A et al. |
Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. |
2016 |
PLoS ONE |
pmid:27311019
|
|
|
|
|
pmid:27311721
|
|
|
|
|
pmid:27318268
|
|
|
|
|
pmid:27328677
|
|
|
|
|
pmid:27334353
|
Dolan EB et al. |
Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. |
2016 |
J R Soc Interface |
pmid:27335224
|
Li Y et al. |
OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. |
2016 |
Medicine (Baltimore) |
pmid:27336899
|
Songia P et al. |
Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. |
2016 |
J. Mol. Cell. Cardiol. |
pmid:27338002
|
|
|
|
|
pmid:27339288
|
|
|
|
|
pmid:27341651
|
|
|
|
|
pmid:27342005
|
Zhou QL et al. |
Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. |
2016 |
Mol Med Rep |
pmid:27357904
|
Dawson S and Lawrie A |
From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. |
2017 |
Pharmacol. Ther. |
pmid:27373854
|
|
|
|
|
pmid:27377060
|